Company intelligence / Profile preview

Novarum DX

Cardiff, Wales, United Kingdom

Ownership: Private
Employees: ~14
Development stage: Other

Overview

Novarum DX provides mobile apps and digital solutions for diagnostic device and assay providers, focusing on smartphone-based readout, reporting, and data integration for lateral flow and other point-of-care diagnostics. Its technology is ISO 13485-certified, with strong traction in the health, wellness, and environmental sectors. The platform is widely deployed, supporting both product-specific apps and modular SaaS for diagnostics. Recent clinical use is not directly disclosed, but the company services providers whose tests are utilized commercially and in clinical research.

Therapeutic areas: OtherInfectious DiseasesEndocrinology
Modalities: DeviceDiagnostic appDigital health technology
Industry: Digital Health Medical Devices

Partnerships

BBI Solutionspartnerships as technical vendor for major diagnostic providers

Beyond the preview

Go deeper on Novarum DX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novarum DX.

Explore the full profile